BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33565048)

  • 61. Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.
    Mayoral K; Rajmil L; Murillo M; Garin O; Pont A; Alonso J; Bel J; Perez J; Corripio R; Carreras G; Herrero J; Mengibar JM; Rodriguez-Arjona D; Ravens-Sieberer U; Raat H; Serra-Sutton V; Ferrer M
    J Med Internet Res; 2019 Nov; 21(11):e14947. PubMed ID: 31714252
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Think of the Children: A Discussion of the Rationale for and Implications of the Perspective Used for EQ-5D-Y Health State Valuation.
    Lipman SA; Reckers-Droog VT; Kreimeier S
    Value Health; 2021 Jul; 24(7):976-982. PubMed ID: 34243841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data.
    Jensen CE; Sørensen SS; Gudex C; Jensen MB; Pedersen KM; Ehlers LH
    Appl Health Econ Health Policy; 2021 Jul; 19(4):579-591. PubMed ID: 33527304
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Crosswalk EQ-5D-5L Value Set for Slovenia.
    Prevolnik Rupel V; Ogorevc M
    Zdr Varst; 2020 Sep; 59(3):189-194. PubMed ID: 32952720
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
    Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
    Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000.
    Inotai A; Nagy D; Kaló Z; Vokó Z
    Qual Life Res; 2024 Jun; ():. PubMed ID: 38839684
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Toward Explicit Prioritization for the Caribbean: An EQ-5D Value Set for Trinidad and Tobago.
    Bailey H; Stolk E; Kind P
    Value Health Reg Issues; 2016 Dec; 11():60-67. PubMed ID: 27986200
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A direct comparison between discrete choice with duration and composite time trade-off methods: do they produce similar results?
    Roudijk B; Jonker MF; Bailey H; Pullenayegum E
    Value Health; 2024 Jun; ():. PubMed ID: 38843979
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
    Verstraete J; Marthinus Z; Dix-Peek S; Scott D
    Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Measurement Properties and Value Set of EuroQol Five-Dimensional Questionnaire-Youth Version].
    Sun Y; Yang ZH; Zhang RY; Wang P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):722-732. PubMed ID: 36065708
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How Significant Are "High" Correlations Between EQ-5D Value Sets?
    Ombler F; Albert M; Hansen P
    Med Decis Making; 2018 Aug; 38(6):635-645. PubMed ID: 29877163
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing].
    Kreimeier S; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies.
    Zrubka Z; Golicki D; Prevolnik-Rupel V; Baji P; Rencz F; Brodszky V; Gulácsi L; Péntek M
    Eur J Health Econ; 2019 Jun; 20(Suppl 1):141-154. PubMed ID: 31102159
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Investigating the relative value of health and social care related quality of life using a discrete choice experiment.
    Mulhern B; Norman R; De Abreu Lourenco R; Malley J; Street D; Viney R
    Soc Sci Med; 2019 Jul; 233():28-37. PubMed ID: 31153085
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets.
    Kularatna S; Chen G; Byrnes J; Scuffham PA
    Value Health Reg Issues; 2017 May; 12():20-23. PubMed ID: 28648311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.
    Kularatna S; Whitty JA; Johnson NW; Scuffham PA
    Health Qual Life Outcomes; 2013 Sep; 11():149. PubMed ID: 24070162
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Child health valuation protocol for a discrete choice experiment comparing paired comparison and kaizen tasks and estimating US EQ-5D-Y-3L values on an experience scale.
    Jumamyradov M; Craig BM; Rivero-Arias O; Jakubczyk M
    BMJ Open; 2023 Oct; 13(10):e077256. PubMed ID: 37879694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.
    Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG
    Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A French Value Set for the EQ-5D-5L.
    Andrade LF; Ludwig K; Goni JMR; Oppe M; de Pouvourville G
    Pharmacoeconomics; 2020 Apr; 38(4):413-425. PubMed ID: 31912325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.